"The voice for cancer physicians and their patients in Massachusetts."
The U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for its lung cancer therapy for the second-line treatment of patients with advanced squamous cell carcinoma of the lung. Read more.
Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451
Waltham, MA. 02451